Insider Transactions in Q3 2024 at Tyra Biosciences, Inc. (TYRA)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2024
|
Todd Harris President and CEO |
SELL
Open market or private sale
|
Direct |
500
-0.03%
|
$12,000
$24.0 P/Share
|
|
Sep 25
2024
|
Todd Harris President and CEO |
SELL
Open market or private sale
|
Direct |
600
-0.04%
|
$14,400
$24.01 P/Share
|
|
Sep 24
2024
|
Todd Harris President and CEO |
SELL
Open market or private sale
|
Direct |
1,055
-0.07%
|
$25,320
$24.02 P/Share
|
|
Sep 23
2024
|
Todd Harris President and CEO |
SELL
Open market or private sale
|
Direct |
10,092
-0.68%
|
$242,208
$24.13 P/Share
|
|
Sep 20
2024
|
Todd Harris President and CEO |
SELL
Open market or private sale
|
Direct |
7,109
-0.48%
|
$170,616
$24.19 P/Share
|
|
Sep 19
2024
|
Todd Harris President and CEO |
SELL
Open market or private sale
|
Direct |
5,698
-0.19%
|
$136,752
$24.7 P/Share
|
|
Sep 18
2024
|
Todd Harris President and CEO |
SELL
Open market or private sale
|
Direct |
3,500
-0.23%
|
$84,000
$24.0 P/Share
|
|
Sep 13
2024
|
Todd Harris President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,350
+0.09%
|
$8,100
$6.58 P/Share
|
|
Sep 13
2024
|
Alan Fuhrman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
954
+22.17%
|
$11,448
$12.48 P/Share
|